A trial looking at fosaprepitant for children and young people to prevent sickness after chemotherapy

Please note

This trial is no longer recruiting patients. We hope to add results when they are available.

Overview

Cancer types:

Children's cancers

Status:

Closed

Phase:

Phase 2

Details

This trial is looking at fosaprepitant [FOS-a-PRE-pi-tant] to help stop sickness in children and young people who are having chemotherapy. This drug is also known as MK 517 or Ivemend.

This trial is for children and young people under the age of 12. We use the term ’you’ in this summary, but if you are a parent, we are referring to your child.

Recruitment start: 11 June 2013

Recruitment end: 29 April 2016